Antipsychotic medication and prefrontal cortex activation: A review of neuroimaging findings

@article{Liemburg2012AntipsychoticMA,
  title={Antipsychotic medication and prefrontal cortex activation: A review of neuroimaging findings},
  author={Edith Jantine Liemburg and Henderikus Knegtering and Hans C Klein and Rudie Kortekaas and Andr{\'e} Aleman},
  journal={European Neuropsychopharmacology},
  year={2012},
  volume={22},
  pages={387-400}
}

Figures and Tables from this paper

Hyper- and Hypomentalizing in Patients with First-Episode Schizophrenia: fMRI and Behavioral Studies

TLDR
The neural pattern of FES patients is consistent with deficits in the ability to switch off mentalizing processes in potentially social contexts, instead increasing them when intentionality is not forthcoming, demonstrating complexities of theory of mind deficits in schizophrenia that should be considered when offering social cognitive training programs.

Reviewing the ketamine model for schizophrenia

TLDR
It is concluded that ketamine challenge is useful for studying the positive, negative, and cognitive symptoms, dopaminergic and GABAergic dysfunction, age of onset, functional dysconnectivity, and abnormal cortical oscillations observed in acute schizophrenia.

Neuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research

TLDR
Current evidence suggests that blood oxygen level-dependant effects of antipsychotic drugs reflect specific, regional effects but studies on the neuropharmacology of auditory hallucinations are scarce.

No difference in frontal cortical activity during an executive functioning task after acute doses of aripiprazole and haloperidol

TLDR
Compared brain activation characteristics produced by aripiprazole with that of haloperidol, a typical D2 receptor antagonist, during a task targeting executive functioning, no significant group differences were obtained.

Phosphodiesterase as a Target for Cognition Enhancement in Schizophrenia.

TLDR
The mechanism of phosphodiesterases in treating the symptoms of schizophrenia is illustrated and the encouraging results of PDE inhibitors as anti-schizophrenic drugs in preclinical and clinical studies are summarised.

Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.

BACKGROUND Patients with schizophrenia have an approximately 10-fold higher risk for obsessive-compulsive symptoms (OCS) than the general population. A large subgroup seems to experience OCS as a

References

SHOWING 1-10 OF 114 REFERENCES

Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia.

TLDR
This study provides direct evidence for significantly enhanced frontal function in schizophrenic patients after substitution of risperidone for typical antipsychotic drugs, and it indicates the potential value of functional MRI as a tool for longitudinal assessment of psychopharmacological effects on cerebral physiology.

Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia

TLDR
The findings partially support the current concept of dopaminergic dysfunction in schizophrenia, suggesting a rather hyperactive mesolimbic dopamine system and reduced prefrontal activation, at least in partially remitted patients treated with atypical antipsychotics.

Prefrontal function in schizophrenia: confounds and controversies.

  • D. WeinbergerK. Berman
  • Psychology, Medicine
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • 1996
TLDR
Overall, the functional neuroimaging database in patients with schizophrenia suggests that prefrontal cognitive deficits are because of prefrontal pathophysiology and not the inverse.

Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia.

TLDR
The results are consistent with the hypotheses that working memory dysfunction in patients with schizophrenia is caused by a disturbance of the dorsolateral prefrontal cortex and that this disturbance is selectively associated with cognitive disorganization.

Beyond hypofrontality: A quantitative meta‐analysis of functional neuroimaging studies of working memory in schizophrenia

TLDR
The complex pattern of hyper‐ and hypoactivation consistently found across studies implies that rather than focusing on DLPFC dysregulation, researchers should consider the entire network of regions involved in a given task when making inferences about the biological mechanisms of schizophrenia.

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

TLDR
The data suggest that the COMT Val allele, because it increases prefrontal dopamine catabolism, impairs prefrontal cognition and physiology, and by this mechanism slightly increases risk for schizophrenia.

Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia

Prefrontal function and activation in bipolar disorder and schizophrenia.

TLDR
Brain activations during the Hayling task differentiated patients with bipolar disorder from comparison subjects and patients with schizophrenia, suggesting that bipolar disorder patients engaged emotional brain areas more than comparison subjects while performing the Haying task.
...